Aprea Therapeutics, Inc. (APRE) Ownership

$1.50

north_east
$0.02 (1.35%)
Day's range
$1.49
Day's range
$1.57

Aprea Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
AIGH CAPITAL MANAGEMENT LLC 10/31/2025 539.30 K $795.47 K   0.00% 8.87%
SPHERA FUNDS MANAGEMENT LTD. 11/14/2025 270.00 K $398.25 K   0.00% 4.44%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2025 205.76 K $303.50 K   0.00% 3.38%
VANGUARD GROUP INC 11/07/2025 158.24 K $233.40 K   -8.98% 2.60%
DAFNA CAPITAL MANAGEMENT LLC 11/14/2025 137.17 K $202.33 K   0.00% 2.25%
SIO CAPITAL MANAGEMENT, LLC 11/13/2025 112.22 K $165.53 K   -59.83% 1.84%
MORGAN STANLEY 11/14/2025 65.81 K $97.07 K   3.91% 1.08%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 44.62 K $65.82 K   3.43% 0.73%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 17.13 K $25.27 K   11.02% 0.28%
LPL FINANCIAL LLC 11/12/2025 16.05 K $23.68 K   -5.86% 0.26%
HIGHTOWER ADVISORS, LLC 11/07/2025 13.86 K $20.45 K   0.00% 0.23%
HRT FINANCIAL LP 11/14/2025 12.26 K $18.00 K   100.00% 0.20%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 11/13/2025 10.50 K $15.48 K   -56.21% 0.17%
BLACKROCK, INC. 11/12/2025 8.50 K $12.54 K   0.00% 0.14%
BANK OF AMERICA CORP /DE/ 11/14/2025 4.86 K $7.17 K   0.10% 0.08%
MB, LEVIS & ASSOCIATES, LLC 10/15/2025 806 $1.19 K   0.00% 0.01%
GROUP ONE TRADING, L.P. 11/12/2025 577 $851   0.00% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 11/14/2025 568 $838   -80.83% 0.01%
ADVISOR GROUP HOLDINGS, INC. 11/14/2025 400 $609   0.00% 0.01%
WEALTHCOLLAB, LLC 11/13/2025 158 $234   0.00% 0.00%
SBI SECURITIES CO., LTD. 11/05/2025 42 $62   5.00% 0.00%
CITIGROUP INC 11/10/2025 5 $7   100.00% 0.00%
UBS GROUP AG 11/13/2025 3 $4   -62.50% 0.00%
FMR LLC 11/13/2025 0 $0   -100.00% 0.00%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 0 $0   -100.00% 0.00%

Aprea Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 30 institutional investors and hedge funds held shares of Aprea Therapeutics, Inc.. The most heavily invested institutionals were:

AIGH Capital Management LLC: 539,300

SPHERA FUNDS MANAGEMENT LTD.: 270,000

Nantahala Capital Management, LLC: 205,760

VANGUARD GROUP INC: 158,238

DAFNA Capital Management LLC: 137,174

Sio Capital Management, LLC: 112,223

26.61% of Aprea Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 1.67 M shares in the last 24 months. This purchase volume represents approximately $2.50 M in transactions.